PROM1 and neoplasm: Correspondingly, low expression of CD133 and CD44 is illustrated in Figure 5C, 5D and Figure 5G, 5H in the tumor tissues from the PDX models, which were established using clinical tissues with low expression of the CD133 and CD44 proteins.